Laboratory of Orofacial Pain, Department of Physiological Sciences, Piracicaba Dental School, University of Campinas - UNICAMP, Piracicaba, SP, Brazil.
São Leopoldo Mandic Institute and Research Center, Campinas, SP, Brazil.
Neuroscience. 2018 Nov 1;391:120-130. doi: 10.1016/j.neuroscience.2018.09.005. Epub 2018 Sep 22.
Temporomandibular joint (TMJ) is frequently involved with rheumatoid arthritis with a high prevalence that could result in a chronic pain state. Once the disease is established in the joint, the antigen-specific immune reaction initiates a neuro-immune cascade of events that causes sensitization of the central nervous system. This study establishes animal experimental models that evaluate the chronicity of albumin-induced arthritis hypernociception in the TMJ. Antigen-induced arthritis was generated in rats with methylated bovine serum albumin (mBSA) diluted in complete Freund's. Intra-articular injection of mBSA (10 µg/TMJ/week) during 3 weeks resulted in a persistent inflammatory hypernociception which was characterized by an inflammatory episode characterized by the increased of lymphocytes, macrophages and pro-inflammatory interleukins IL-12 and IL-18. The persistent model of inflammatory hypernociception induced by arthritis in the TMJ elicited protein levels of P2X7 receptors, cathepsin S and fractalkine in the trigeminal subnucleus caudalis. Overall, the results of the present work suggest that a persistent inflammatory hypernociception of albumin-induced arthritis in the TMJ leads to the activation of the central nervous system signaling by P2X7/cathepsin S/fractalkine pathway.
颞下颌关节(TMJ)常与类风湿关节炎有关,其患病率较高,可能导致慢性疼痛状态。一旦疾病在关节中确立,抗原特异性免疫反应就会引发一系列神经免疫事件,导致中枢神经系统敏化。本研究建立了动物实验模型,评估了卵清蛋白诱导的 TMJ 关节炎痛觉过敏的慢性病程。用甲基化牛血清白蛋白(mBSA)在完全弗氏佐剂中稀释,在大鼠中产生抗原诱导的关节炎。在 3 周内每周向 TMJ 关节内注射 10μg/mBSA,导致持续的炎症性痛觉过敏,其特征是炎症发作伴有淋巴细胞、巨噬细胞和促炎细胞因子 IL-12 和 IL-18 的增加。关节炎诱导的 TMJ 炎症性痛觉过敏的持续模型引起三叉神经尾核亚核中 P2X7 受体、组织蛋白酶 S 和 fractalkine 的蛋白水平升高。总的来说,本工作的结果表明,TMJ 卵清蛋白诱导的关节炎的持续炎症性痛觉过敏会通过 P2X7/组织蛋白酶 S/fractalkine 途径激活中枢神经系统信号。
Eur J Pharmacol. 2014-7-10
Front Immunol. 2025-7-7
Genes (Basel). 2023-2-4
Front Pain Res (Lausanne). 2021-7-9